TNFRSF8 and mature T-cell and NK-cell non-Hodgkin lymphoma: Herein, we demonstrate an effective CAR-T cell treatment for recurrent and malignant CD30-positive peripheral T-cell lymphomas (PTCL) has been demonstrated.